HeraMED's Trading Halt Request

HeraMED Limited (ASX: $HMD) has requested a trading halt for up to two trading days to make an announcement regarding changes in Directors and Management, restructure of the business, and associated capital requirements, including the Shortfall of the Rights Issue. The trading halt will remain in place until the announcement is released or prior to the commencement of trading on Friday, 5 April 2024.

Director's Trading Halt Request Statement

The trading halt request is made in anticipation of significant changes within the company's leadership and business structure, as well as to address the capital requirements, including the Shortfall of the Rights Issue. The company is committed to providing timely and transparent information to the market regarding these developments.

Summary of HeraMED's Trading Halt Request

HeraMED Limited (ASX: $HMD) has requested a trading halt to prepare for an announcement concerning changes in Directors and Management, business restructuring, and capital requirements, including the Shortfall of the Rights Issue. The company aims to ensure that the market is informed about these impending developments and is dedicated to maintaining transparency throughout this process. The trading halt will be in place until the announcement is made or before the commencement of trading on Friday, 5 April 2024.